David P Perry's Net Worth
$2.78 Million
Who is David P Perry?
David P Perry has an estimated net worth of $2.78 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals, Inc., Evelo Biosciences, Inc., Better Therapeutics, Inc., and NEXPRISE INC.
SEC CIK
David P Perry's CIK is 0001105941
Past Insider Trading and Trends
2021 was David P Perry's most active year for acquiring shares with 15 total transactions. David P Perry's most active month to acquire stocks was the month of April. 2014 was David P Perry's most active year for disposing of shares, totalling 8 transactions. David P Perry's most active month to dispose stocks was the month of November. 2023 saw David P Perry paying a total of $4,999,999.57 for 6,217,742 shares, this is the most they've acquired in one year. In 2014 David P Perry cashed out on 145,000 shares for a total of $2,630,510.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.25% | -65.00K |
$20.22 | -$1,314,396.50 | 361.31K |
Scheduled
|
Mar 4 - Mar 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| -3.40% | -15.00K |
$17.00 | -$255,006.75 | 426.31K |
Scheduled
|
Feb 4 - Feb 5
| ||
Form 4
| -12.84% | -65.00K |
$16.32 | -$1,061,107.00 | 441.31K |
Scheduled
|
Jan 8 - Jan 9
| ||
Form 4
| +93.87% | 245.15K |
$8.42 | -$483,299.26 | 506.31K |
Scheduled
|
Dec 5 - Dec 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0475
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8 - Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Better Therapeutics, Inc. (BTTX) Snapshot price: $0.1702
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.27% | 839.89K |
$0.19 | $160,000.00 | 2.42M |
Feb 9
| |||
Form 4
| +1,397.58% | 1.47M |
$0.17 | $249,999.86 | 1.58M |
Jan 9
| |||
Form 4
| +3.69% | 3.75K |
—
|
—
| 105.29K |
Dec 18
| |||
Form 4
| +10.45% | 1.23M |
$0.73 | $899,999.55 | 13.03M |
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +47.49% | 4.97M |
$0.83 | $4,100,000.02 | 15.43M |
Apr 10
| |||
Form 4
| +97.02% | 50K |
$2.05 | $102,597.54 | 101.54K |
Sep 15 - Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +34.59% | 10.83M |
$9.97 | $3,512,432.48 | 42.14M |
Apr 30 - Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEXPRISE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
| No matching records found | |||||||||